BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia

References

• Estey E, Döhmer H. Acute myeloid leukaemia. Lancet 2006; 368: 1894–1907.
   PubMed Web of Science ®Google Scholar
• Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 2009; 114: 1150–1157.
   PubMed Web of Science ®Google Scholar
• Grimwade D. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract Res Clin Haematol 2001; 14: 497–529.
   PubMed Web of Science ®Google Scholar
• Byrd JC, Mrózek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325–4336.
   PubMed Web of Science ®Google Scholar
• Mrózek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007; 109: 431–448.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937–951.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059–2074.
   PubMed Web of Science ®Google Scholar
• Hou HA, Lin CC, Chou WC, et al. Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia. Leukemia 2014; 28: 50–58.
   PubMed Web of Science ®Google Scholar
• Mrózek K, Döhner H, Bloomfield CD. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances. Curr Opin Hematol 2007; 14: 106–114.
   PubMed Web of Science ®Google Scholar
• Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002; 2: 777–785.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang M, Gan L, et al. DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis. Int J Biol Sci 2012; 8: 1178–1187.
   PubMed Web of Science ®Google Scholar
• Schwartz AM, Man YG, Rezaei MK, et al. BP1, a homeoprotein, is significantly expressed in prostate adenocarcinoma and is concordant with prostatic intraepithelial neoplasia. Mod Pathol 2009; 22: 1–6.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Z, Guo X, et al. DLX4 as a prognostic marker for hepatocellular carcinoma. Neoplasma 2014; 61: 318–323.
   PubMed Web of Science ®Google Scholar
• Yu M, Wan YF, Zou QH. Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer. Clin Biochem 2008; 41: 824–830.
   PubMed Web of Science ®Google Scholar
• Yu M, Yang Y, Shi Y, et al. Expression level of beta protein 1 mRNA in Chinese breast cancer patients: a potential molecular marker for poor prognosis. Cancer Sci 2008; 99: 173–178.
   PubMed Web of Science ®Google Scholar
• Haga SB, Fu S, Karp JE, et al. BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia 2000; 14: 1867–1875.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
   Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620–625.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin J, Yang J, et al. Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia. Leuk Res 2013; 37: 1642–1647.
   PubMed Web of Science ®Google Scholar
• Lin J, Yao DM, Qian J, et al. Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 2011; 6: e26906.
   PubMed Web of Science ®Google Scholar
• Lin J, Yao DM, Qian J, et al. IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Ann Hematol 2012; 91: 519–525.
   PubMed Web of Science ®Google Scholar
• Yang X, Qian J, Sun A, et al. RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia. Clin Biochem 2013; 46: 579–583.
   PubMed Web of Science ®Google Scholar
• Qian J, Yao DM, Lin J, et al. U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 2012; 7: e45760.
   PubMed Web of Science ®Google Scholar
• Wen XM, Lin J, Yang J, et al. Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD. Int J Clin Exp Pathol 2014; 7: 6832–6840.
   PubMed Web of Science ®Google Scholar
• Kraus P, Lufkin T. Dlx homeobox gene control of mammalian limb and craniofacial development. Am J Med Genet A 2006; 140: 1366–1374.
   PubMed Web of Science ®Google Scholar
• Mpollo MS, Beaudoin M, Berg PE, et al. BP1 is a negative modulator of definitive erythropoiesis. Nucleic Acids Res 2006; 34: 5232–5237.
   PubMed Web of Science ®Google Scholar
• Tamaoki N, Takahashi K, Aoki H, et al. The homeobox gene DLX4 promotes generation of human induced pluripotent stem cells. Sci Rep 2014; 4: 7283.
   PubMed Web of Science ®Google Scholar
• Sun Y, Lu X, Yin L, et al. Inhibition of DLX4 promotes apoptosis in choriocarcinoma cell lines. Placenta 2006; 27: 375–383.
   PubMed Web of Science ®Google Scholar
• Man YG, Fu SW, Schwartz A, et al. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat 2005; 90: 241–247.
   PubMed Web of Science ®Google Scholar
• Awwad RT, Do K, Stevenson H, et al. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells. Ann Hematol 2008; 87: 195–203.
   PubMed Web of Science ®Google Scholar